Signaling pathways
-
BA7797 M1002Summary: M1002 is a hypoxia-inducible factor-2 agonist that enhances the expression of HIF-2 target genes. - BA7798 MK-8617Summary: An orally active pan-inhibitor of the hypoxia-inducible factor prolyl hydroxylase 1-3.
- BA7799 HIF-1α-IN-2Summary: HIF-1α-IN-2 is a potent inhibitor with anticancer effects.
- BA7800 AKB-6899Summary: AKB-6899 is a prolyl hydroxylase domain 3 inhibitor and a selective stabilizer.
- BA7801 TAT-cyclo-CLLFVYSummary: TAT-cyclo-CLLFVY is a heterodimerized cyclic peptide inhibitor that inhibits hypoxic signaling in cancer cells.
-
BA7802 SYP-5Summary: SYP-5 is a novel inhibitor. - BA7803 DesidustatSummary: Desidustat is a hydroxylase inhibitor with oral activity.
- BA7804 FM19G11Summary: FM19G11 is an inhibitor.
- BA7805 HIF-2α-IN-4Summary: HIF-2α-IN-4 is a potent translational inhibitor.
- BA7806 TP0463518Summary: A potent inhibitor of the hypoxia-inducible factor prolyl hydroxylase(s).